Viewing Study NCT06237920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-01-29 @ 3:40 PM
Study NCT ID: NCT06237920
Status: RECRUITING
Last Update Posted: 2025-09-03
First Post: 2023-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
Sponsor: The Netherlands Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urologic Neoplasms View
None Urogenital Neoplasms View
None Neoplasms by Site View
None Neoplasms View
None Female Urogenital Diseases View
None Female Urogenital Diseases and Pregnancy Complications View
None Urogenital Diseases View
None Urinary Bladder Diseases View
None Male Urogenital Diseases View
None Urinary Bladder Neoplasm View
None Antineoplastics Toxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nivolumab View
None Relatlimab View